within Pharmacolibrary.Drugs.ATC.C;

model C03AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.09,
    Cl             = 300 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 1200
  );

  annotation(Documentation(
    info ="<html><body><p>Chlorothiazide is a thiazide diuretic used for the management of hypertension and edema related to congestive heart failure, liver cirrhosis, or corticosteroid and estrogen therapy. It acts primarily on the distal convoluted tubule in the kidney to promote sodium and water excretion. Chlorothiazide remains approved and in clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after a single oral dose.</p><h4>References</h4><ol><li><p>Bohn, BC, et al., &amp; Shuster, JE (2019). Oral Metolazone Versus Intravenous Chlorothiazide as an Adjunct to Loop Diuretics for Diuresis in Acute Decompensated Heart Failure With Reduced Ejection Fraction. <i>Hospital pharmacy</i> 54(6) 351–357. DOI:<a href=&quot;https://doi.org/10.1177/0018578718795855&quot;>10.1177/0018578718795855</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31762481/&quot;>https://pubmed.ncbi.nlm.nih.gov/31762481</a></p></li><li><p>Sörgel, F, et al., &amp; Williams, RL (1985). Oral triamterene disposition. <i>Clinical pharmacology and therapeutics</i> 38(3) 306–312. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1985.176&quot;>10.1038/clpt.1985.176</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4028626/&quot;>https://pubmed.ncbi.nlm.nih.gov/4028626</a></p></li><li><p>Barbhaiya, RH, et al., &amp; Welling, PG (1982). Comparative bioavailability and pharmacokinetics of hydrochlorothiazide from oral tablet dosage forms, determined by plasma level and urinary excretion methods. <i>Biopharmaceutics &amp; drug disposition</i> 3(4) 329–336. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510030406&quot;>10.1002/bdd.2510030406</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7159688/&quot;>https://pubmed.ncbi.nlm.nih.gov/7159688</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C03AA04;
